Novabay pharmaceuticals, inc. (NBY)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities:
Net loss

-7,051

-9,658

-8,240

-9,496

-8,584

-6,545

-4,484

-5,393

-5,542

-7,403

-9,844

-11,133

-12,085

-13,151

-15,707

-17,213

-19,410

-18,973

0

0

0

-

-

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Depreciation and amortization

62

65

97

172

242

266

260

186

118

95

70

83

92

114

139

149

163

164

170

173

203

232

0

0

0

Net realized loss on sales of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-40

0

0

0

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

2

57

54

0

0

0

Impairment of operating lease right-of-use assets

0

125

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense for options and stock issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Stock option modification expense

-

-

-

-

-

77

338

581

581

504

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense for options and stock issued to consultants and advisory board members

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Issuance of RSUs to employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

133

-

0

0

0

-

-

-

-

Issuance of RSUs to non-employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

21

-

0

0

0

-

-

-

-

Allowance for doubtful accounts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Note receivable impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

91

91

91

91

0

0

0

0

-

-

-

-

Non-cash loss on change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Non-cash (gain) loss on changes in fair value of warrant liability

-943

-749

-1,276

-63

-1,040

-1,311

-1,371

-823

-348

101

0

0

0

-

-

-

-

-2,149

1,213

1,283

486

0

0

0

0

Non-cash gain on changes in fair value of embedded derivative liability

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense related to amortization of debt issuance and debt discount

755

670

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense related to amortization of debt issuance related to related party notes payable

14

18

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-1,478

-2,319

-1,108

-489

206

-774

-146

-2,105

-636

1,509

150

2,111

835

1,585

1,536

1,102

1,143

299

335

-1

86

-555

0

0

0

Inventory

250

212

0

0

0

-

-

-

-

-369

-484

-442

-436

-472

-511

-350

636

751

1,277

1,334

498

451

0

0

0

Prepaid expenses and other current assets

897

888

-291

-113

29

-97

251

627

696

-313

-906

253

442

1,470

1,032

-115

-786

-402

92

-121

318

-102

0

0

0

Operating lease right-of-use assets

-841

-861

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets long-term

-

-

-

-

-

-

207

207

237

73

0

0

293

-

0

0

0

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

-1,454

-1,800

-979

-568

156

516

-918

-977

-655

-260

169

-435

-1,646

-2,356

-1,337

398

810

1,643

1,920

834

1,257

-252

0

0

0

Operating lease liabilities

-1,062

-1,066

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-69

-61

-53

-45

27

308

374

383

327

0

0

0

-

-

-

-

-

-

-

-

Deferred revenue

559

-41

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party notes payable

217

204

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Decrease) Increase in Deferred revenue

-

-

-

-

-

-

-

-

-

-

0

0

492

-

848

1,180

793

6

-72

611

613

553

0

0

0

Long-term obligations

35

42

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Increase (decrease) in deferred revenue

-

-

-

-

-

-69

-61

-53

-45

27

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-5,573

-7,929

-8,493

-8,611

-8,325

-5,568

-6,501

-4,602

-4,728

-6,270

0

0

0

-

-

-

-

-

-

-

0

-

0

0

0

Investing activities:
Purchases of property and equipment

-

19

50

58

56

44

29

94

187

244

310

277

203

160

155

139

125

123

51

69

70

68

0

0

0

Proceeds from disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37

0

0

0

-

-

-

-

Purchases of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,012

0

0

0

Proceeds from maturities and sales of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,550

0

0

0

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-19

-50

-58

-56

-44

-29

-94

-187

-244

0

0

0

-

-

-

-

-

-

-

0

-

0

0

0

Proceeds from common stock issuances, net

-

-

-

-

-

5,585

0

0

0

-

0

3,773

11,020

13,648

25,167

21,394

14,147

11,519

48

153

187

227

0

0

0

Proceeds from issuance of related party notes payable

-

1,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of options, net

-

-

-

-

-

11

67

196

196

185

0

0

0

-

-

-

-

-

-

-

-

0

0

0

0

Proceeds from stock options & RSUs sold to cover taxes

-

4

4

4

4

1

10

27

27

26

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from restricted stock sold to cover taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Settlement of restricted stock for tax withholding

-

-

-

-

-

-

-

-

-

48

0

0

37

-

0

0

0

-

-

-

-

-

-

-

-

Proceeds from convertible notes, net of discount

-

2,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment on the convertible note

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt issuance cost

-

202

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

1,365

3,020

3,020

3,020

1,655

0

0

0

-

-

-

-

Proceeds from shelf offering, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,177

12,377

12,294

5,267

7,125

0

0

0

Net cash (used) provided in financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

8,354

11,702

12,356

5,504

2,978

5,597

5,662

5,808

5,852

201

0

0

0

-

-

-

-

-

-

-

0

-

0

0

0

Net decrease in cash, cash equivalents, and restricted cash

2,776

3,754

3,813

-3,165

-5,403

-15

-868

1,112

937

-6,313

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of cash flow information:
Interest paid

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Cumulative effect of adoption of New ASU

-

-

-

-

-

2,638

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Addition of operating lease, right-of-use asset

-

2,473

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued to consultants for services, included in accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

1

2

5

8

8

70

67

64

63

0

0

0

-

-

-

-

Fixed asset purchases, included in accounts payable and accrued liabilities

-

10

-46

-40

-57

-49

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Fixed asset purchases, included in accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Proceeds from stock options and restricted stock for taxes, in accounts payable and accrued liabilities

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Employee [Member]
Issuance of RSUs

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounting Standards Update 2014-09 [Member]
Cumulative effect of adoption of New ASU

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-